∙ Lupin receives tentative approval from USFDA for Tolvaptan tablets.   ∙ Tolvaptan Tablets had estimated annual sales of $287 mn in the US. 

Scribbled Underline 2
Scribbled Underline 2

∙ Organic business delivered steady performance with mid-single digit volume growth.   ∙ Home care volumes grew in mid-single digit; personal care grew in low-single digit.  ∙ Indonesia biz to improve further, with double-digit volume & value growth. 

Scribbled Underline 2
Scribbled Underline 2

∙ Total – Standalone business down 13% YoY, volume up 11% YoY.   ∙ Edible oil business down 19% YoY, volume up 5% YoY.  ∙Food & FMCG business up 25% YoY, volume up 18% YoY. 

Swipe up to

Arrow